September 12, 2018

BioWorld: OncoResponse completes $40M series B, shifting from discovery to development

September 11, 2018

ENDPOINTS: Focusing on the tumor microenvironment, OncoResponse garners $40 million for the next stage of the R&D journey

September 11, 2018

BioCentury: OncoResponse moves into clinic with $40M series B

September 11, 2018

FierceBiotech: OncoResponse raises $40M for cancer patient-sourced antibodies

September 11, 2018

Xconomy: OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies

August 8, 2016

BioCentury: Emerging Company Profile: Interrogating Immunity

October 7, 2015

BioWorld: Theraclone, MD Anderson target super-responders in IO start-up

October 6, 2015

Xconomy: Houston’s M.D. Anderson, Theraclone Launch Immunotherapy Startup

October 6, 2015

FierceBiotech: Hub-building MD Anderson partners with Theraclone on $9.5M biotech startup

October 6, 2015

GEN: MD Anderson, Theraclone Launch Immuno-Oncology Antibody Discovery Company